DK467487A - Polypeptid, anvendeligt til lindring, behandling og diagnosticering af autoimmunitetssygdomme, isaer arthritis - Google Patents
Polypeptid, anvendeligt til lindring, behandling og diagnosticering af autoimmunitetssygdomme, isaer arthritisInfo
- Publication number
- DK467487A DK467487A DK467487A DK467487A DK467487A DK 467487 A DK467487 A DK 467487A DK 467487 A DK467487 A DK 467487A DK 467487 A DK467487 A DK 467487A DK 467487 A DK467487 A DK 467487A
- Authority
- DK
- Denmark
- Prior art keywords
- diagnostication
- isaer
- arthritis
- auto
- relief
- Prior art date
Links
- 206010003246 arthritis Diseases 0.000 title 1
- 230000005784 autoimmunity Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
- G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
- G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL8602270A NL8602270A (nl) | 1986-09-09 | 1986-09-09 | Gebruik van een peptide voor de bereiding van preparaten voor het verlichten, het behandelen en de diagnose van autoimmuunziekten, in het bijzonder arthritische toestanden, verbindingen die met dit peptide verwant zijn, alsmede farmaceutische en diagnostische preparaten en testkits. |
| NL8701163A NL8701163A (nl) | 1986-09-09 | 1987-05-14 | Gebruik van een peptide voor de bereiding van preparaten voor het verlichten, het behandelen en de diagnose van autoimmuunziekten, in het bijzonder arthritische toestanden, verbindingen die met dit peptide verwant zijn, alsmede farmaceutische en diagnostische preparaten en testkits. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK467487D0 DK467487D0 (da) | 1987-09-08 |
| DK467487A true DK467487A (da) | 1988-03-10 |
Family
ID=26646154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK467487A DK467487A (da) | 1986-09-09 | 1987-09-08 | Polypeptid, anvendeligt til lindring, behandling og diagnosticering af autoimmunitetssygdomme, isaer arthritis |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0262710B1 (xx) |
| JP (1) | JP2505213B2 (xx) |
| AU (1) | AU601765B2 (xx) |
| CA (1) | CA1315225C (xx) |
| DE (1) | DE3781078T2 (xx) |
| DK (1) | DK467487A (xx) |
| IL (1) | IL83817A (xx) |
| NL (1) | NL8701163A (xx) |
| NO (1) | NO873699L (xx) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4952395A (en) * | 1987-02-26 | 1990-08-28 | Scripps Clinic And Research Foundation | Mycobacterial recombinants and peptides |
| US4976958A (en) * | 1987-02-26 | 1990-12-11 | Scripps Clinic And Research Foundation | Mycobacterial recombinants and peptides |
| NL8703107A (nl) * | 1987-12-22 | 1989-07-17 | Nederlanden Staat | Polypeptiden en derivaten daarvan, alsmede de toepassing daarvan in farmaceutische en diagnostische preparaten. |
| ES2051989T3 (es) * | 1988-10-21 | 1994-07-01 | Akzo Nv | Un procedimiento para la manufactura de una inmunotoxina para el tratamiento o profilaxis de una enfermedad autoinmune. |
| US5578303A (en) * | 1989-03-14 | 1996-11-26 | Yeda Research And Development Co. Ltd. | Diagnosis and treatment of insulin dependent diabetes mellitus |
| US5114844A (en) * | 1989-03-14 | 1992-05-19 | Yeda Research And Development Co., Ltd. | Diagnosis and treatment of insulin dependent diabetes mellitus |
| US5780034A (en) * | 1989-03-14 | 1998-07-14 | Yeda Research And Development Co. Ltd. | Diagnosis and treatment of insulin dependent diabetes mellitus using heat shock protein determinents |
| GB8919321D0 (en) * | 1989-08-25 | 1989-10-11 | Univ London | Treatment of chronic inflammatory conditions |
| GB9024320D0 (en) * | 1990-11-08 | 1990-12-19 | Univ London | Treatment of uveitis |
| AU4762893A (en) * | 1992-07-15 | 1994-02-14 | Rijksuniversiteit Leiden | Hla-dr3 blocking peptides and their use in the treatment of hla-dr3 associated autoimmune diseases. |
| DK0700445T3 (da) | 1993-06-04 | 2002-05-13 | Whitehead Biomedical Inst | Stressproteiner og anvendelser deraf |
| DK0751957T3 (da) * | 1994-03-21 | 2004-06-01 | Univ Utrecht | Peptid-fragmenter af mikrobielle stressproteiner og farmaceutisk sammensætning fremstillet deraf til behandling og forebyggelse af inflammatoriske sygdomme |
| US7157089B1 (en) | 1996-11-26 | 2007-01-02 | Stressgen Biotechnologies Corporation | Immune responses using compositions containing stress proteins |
| IL134341A0 (en) | 1997-08-05 | 2001-04-30 | Stressgen Biotechnologies Corp | Compositions for inducing an immune response containing an hpv protein antigen |
| US6497880B1 (en) | 1998-12-08 | 2002-12-24 | Stressgen Biotechnologies Corporation | Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus |
| JP2003504074A (ja) | 1999-07-08 | 2003-02-04 | ストレスゲン バイオテクノロジーズ コーポレイション | インビトロでのＴｈ１様応答の誘導 |
| EP1253939B1 (en) | 2000-01-14 | 2009-08-05 | Whitehead Institute For Biomedical Research | In vivo ctl elicitation by heat shock protein fusion proteins maps to a discrete atp binding domain and is cd4+ t cell-independent |
| IL153474A0 (en) | 2000-06-26 | 2003-07-06 | Stressgen Biotechnologies Corp | Human papilloma virus treatment |
| US6989146B2 (en) * | 2000-08-09 | 2006-01-24 | The Regents Of The University Of California | Stress proteins and peptides and methods of use thereof |
| PL373675A1 (en) | 2001-02-05 | 2005-09-05 | Stressgen Biotechnologies Corporation | Hepatitis b virus treatment |
| WO2003063759A2 (en) | 2002-01-31 | 2003-08-07 | Peptor Ltd. | Hsp peptides and analogs for modulation of immune responses via antigen presenting cells |
| ES2433915T3 (es) | 2002-05-21 | 2013-12-13 | Irun R. Cohen | Vacunas de ADN que codifican proteínas de choque térmico |
| CU23504A1 (es) | 2004-09-24 | 2010-04-13 | Ct Ingenieria Genetica Biotech | Péptidos y derivados tipo apl de la hsp60 y composiciones farmacéuticas |
| WO2006072946A2 (en) | 2005-01-04 | 2006-07-13 | Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science | Hsp60, hsp60 peptides and t cell vaccines for immunomodulation |
| AU2006224216B2 (en) | 2005-03-14 | 2011-12-08 | B.G. Negev Technologies And Applications Ltd. | Compositions of HSP60 peptides and viral antigens for vaccination and diagnosis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL71683A0 (en) * | 1984-04-27 | 1984-09-30 | Yeda Res & Dev | Pharmaceutical compositions for treating arthritis type diseases comprising fractions obtained from mycobacteria |
-
1987
- 1987-05-14 NL NL8701163A patent/NL8701163A/nl not_active Application Discontinuation
- 1987-09-04 NO NO873699A patent/NO873699L/no unknown
- 1987-09-07 IL IL83817A patent/IL83817A/xx unknown
- 1987-09-07 EP EP87201691A patent/EP0262710B1/en not_active Expired - Lifetime
- 1987-09-07 AU AU78000/87A patent/AU601765B2/en not_active Ceased
- 1987-09-07 DE DE8787201691T patent/DE3781078T2/de not_active Expired - Lifetime
- 1987-09-08 DK DK467487A patent/DK467487A/da not_active Application Discontinuation
- 1987-09-09 CA CA000546494A patent/CA1315225C/en not_active Expired - Fee Related
- 1987-09-09 JP JP62226221A patent/JP2505213B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IL83817A (en) | 1993-01-31 |
| NO873699L (no) | 1988-03-10 |
| DE3781078D1 (de) | 1992-09-17 |
| NL8701163A (nl) | 1988-04-05 |
| IL83817A0 (en) | 1988-02-29 |
| JP2505213B2 (ja) | 1996-06-05 |
| JPS63126895A (ja) | 1988-05-30 |
| DE3781078T2 (de) | 1992-12-24 |
| EP0262710A1 (en) | 1988-04-06 |
| CA1315225C (en) | 1993-03-30 |
| NO873699D0 (no) | 1987-09-04 |
| EP0262710B1 (en) | 1992-08-12 |
| AU7800087A (en) | 1988-03-17 |
| DK467487D0 (da) | 1987-09-08 |
| AU601765B2 (en) | 1990-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK467487A (da) | Polypeptid, anvendeligt til lindring, behandling og diagnosticering af autoimmunitetssygdomme, isaer arthritis | |
| DK442788D0 (da) | Fremgangsmaade og praeparat til behandling af non-ige-medierede lidelser | |
| DK164876C (da) | Fremgangsmaade til fremstilling af et human faktor viii,dna-sekvens, rekombinant udtrykkelsesvektor, dna-sekvensen, cellelinie og rekombinant organisme, anvendelse af polypeptidet til fremstilling af et laegemiddel og farmaceutisk praeparat indeholdende saaledes fremstillet faktor viii polypeptid | |
| DK597288A (da) | Rekombinant, humant immunoglobulin og fremgangsmaade til fremstilling deraf | |
| DK662887D0 (da) | Fladeformigt terapeutisk system, fremgangsmaade til fremstilling deraf og anvendelse deraf | |
| NO882385L (no) | Polypeptid og produksjon derav. | |
| DK122687A (da) | Polypeptid, dna og anvendelse deraf | |
| NO164219C (no) | Fremgangsmaate og anlegg for behandling av returnert boreslam. | |
| DK554485A (da) | Geltandplejemiddel og fremgangsmaade til fremstilling deraf | |
| DK551287A (da) | Polypeptid | |
| NO891006D0 (no) | Terapeutisk aktivt polypeptid og fremgangsmaate for dets fremstilling. | |
| DK360687A (da) | Bestraalingsanordning til medicinsk behandling | |
| DE3886517T2 (de) | Menschlicher Prourokinase ähnliches Polypeptid. | |
| DK152587A (da) | Bestraalingsanordning til medicinsk behandling | |
| NO874114D0 (no) | Fluidums trykkregulering og fremgangsmaate. | |
| DK24887A (da) | Bestraalingsanordning til medicinsk behandling | |
| DK24987A (da) | Bestraalingsanordning til medicinsk behandling | |
| DK650087A (da) | Bestraalingsanordning til medicinsk behandling | |
| DK24587D0 (da) | Bestraalingsanordning til medicinsk behandling | |
| DK20687A (da) | Polypeptidforbindelser og fremgangsmaade til fremstilling deraf | |
| DK670588A (da) | Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet | |
| DK287288D0 (da) | Polypeptid og fremgangmaade til fremstilling deraf | |
| NO872634D0 (no) | Fremgangsmaate og anlegg for behandling av amoniakk. | |
| NO875144L (no) | Plant, terapeutisk system, fremgangsmÿte for fremstilling og anvendelse derav. | |
| ATE98990T1 (de) | Menschlicher prourokinase aehnliches polypeptid. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A0 | Application filed | ||
| AHB | Application shelved due to non-payment |